Parametric Portfolio Associates’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$685K Buy
43,161
+7,340
+20% +$127K ﹤0.01% 2949
2021
Q4
$782K Sell
35,821
-13,913
-28% -$380K ﹤0.01% 2885
2021
Q3
$1.49M Sell
49,734
-11,463
-19% -$417K ﹤0.01% 2605
2021
Q2
$2.71M Sell
61,197
-39,885
-39% -$1.73M ﹤0.01% 2264
2021
Q1
$4.49M Buy
101,082
+55,007
+119% +$3.02M ﹤0.01% 2259
2020
Q4
$2.53M Buy
46,075
+32,328
+235% +$1.18M ﹤0.01% 2514
2020
Q3
$314K Sell
13,747
-96
-0.7% -$2.37K ﹤0.01% 3466
2020
Q2
$290K Buy
13,843
+3,119
+29% +$56.2K ﹤0.01% 3485
2020
Q1
$150K Sell
10,724
-13,338
-55% -$264K ﹤0.01% 3629
2019
Q4
$548K Buy
24,062
+998
+4% +$16.7K ﹤0.01% 3340
2019
Q3
$269K Buy
23,064
+10,659
+86% +$132K ﹤0.01% 3594
2019
Q2
$186K Buy
+12,405
New +$216K ﹤0.01% 3756
2017
Q3
Sell
-7,045
Closed -$54K 4047
2017
Q2
$54K Sell
7,045
-107
-1% -$798 ﹤0.01% 3961
2017
Q1
$57K Buy
+7,152
New +$48.1K ﹤0.01% 3732

Other funds holding RCKT